We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current FNCH market cap is 2.89M. The company's latest EPS is USD -46.5536 and P/E is -0.24.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 8k | 107k | 0 | 0 | 0 |
| Operating Income | -27.75M | -54.23M | -8.29M | -3.78M | -4.42M |
| Net Income | -27.01M | -67.4M | -1.9M | -9.34M | 3.88M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 10.15M | 7.72M | 18.53M | 861k | 107k |
| Operating Income | -21.14M | -39.44M | -59.99M | -115.59M | -70.72M |
| Net Income | -20.75M | -39.34M | -58.16M | -114.65M | -74.75M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 162.94M | 79.04M | 66.86M | 59.49M | 55.37M |
| Total Liabilities | 67.23M | 46.09M | 38.96M | 33.68M | 32.49M |
| Total Equity | 95.71M | 32.95M | 27.89M | 25.81M | 22.89M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 103.57M | 165.34M | 225.37M | 162.94M | 55.37M |
| Total Liabilities | 19.95M | 28M | 23.15M | 67.23M | 32.49M |
| Total Equity | -59.54M | -95.72M | 202.22M | 95.71M | 22.89M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -74.85M | -13.38M | -22.54M | -27.8M | -31.51M |
| Investing | -2.18M | -14k | 1.26M | 1.28M | 1.33M |
| Financing | 14.87M | -16.16M | -16.16M | -16.16M | -16.16M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -17.32M | -31.33M | -67.13M | -74.85M | -31.51M |
| Investing | -973k | -2.63M | -15.92M | -2.18M | 1.33M |
| Financing | 53.3M | 91.48M | 119.11M | 14.87M | -16.16M |
| Market Cap | 2.89M |
| Price to Earnings Ratio | -0.24 |
| Price to Sales Ratio | 165.17 |
| Price to Cash Ratio | 0.7 |
| Price to Book Ratio | 0.77 |
| Dividend Yield | - |
| Shares Outstanding | 1.61M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.24 (11.48%) |
| Company Name | Finch Therapeutics Group Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.finchtherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
